The global enteral feeding devices market, valued at US$2,807.9 million in 2024, stood at US$2,965.1 million in 2025 and is projected to advance at a resilient CAGR of 6.0% from 2025 to 2030, ...

An innovative treatment for debilitating and often deadly cases of recurrent C diff infection has been given a Breakthrough Therapy Designation by the FDA. Developed by US biotech firm Rebiotix ...

However, studies in healthy men using nasoduodenal tubes to bypass the stomach and enable intestinal delivery of a high-fat, mixed macronutrient, liquid formula demonstrated that acute exenatide ...

Second, a Canadian randomised placebo-controlled trial in 21 individuals comparing a single dose of allogenic with autologous FMT via nasoduodenal tube found an improvement in intestinal barrier ...